Evaluation method for arteriosclerosis
AssigneeHitachi, Ltd.
InventorsHiroko Hanzawa, Takeshi Sakamoto, Naomi Manri, Yuji Kuge
Life of this patent
Estimating the term…
Loading patent…
AssigneeHitachi, Ltd.
InventorsHiroko Hanzawa, Takeshi Sakamoto, Naomi Manri, Yuji Kuge
Estimating the term…
Arteriosclerosis induces cerebral infarction and myocardial infarction. A multi-marker (a group of protein markers) that assesses the accurate pathogenesis of arteriosclerosis and enables the selection of an adequate treatment method for arteriosclerosis and prediction of the progression of arteriosclerosis, and an evaluation method for the diagnosis, prevention, and treatment of arteriosclerosis that uses said marker group as an indicator have been sought. The present invention relates to A method for evaluation of arteriosclerosis comprising the steps of (a) measuring the expression of von Willebrand factor and/or complement factor D in a sample derived from a subject, (b) measuring the expression of complement component C8 and/or vitamin K-dependent protein Z in the sample derived from the subject, and (c) evaluating arteriosclerosis in the subject on the basis of the results from (a) and (b).
A method for evaluation of arteriosclerosis, comprising the steps of:
A method for evaluation of arteriosclerosis, comprising the steps of:
A method for evaluation of arteriosclerosis, comprising the steps of:
Dependencies are inferred from the claim text.